Analysis of core region from egg white lysozyme forming amyloid fibrils

International Journal of Biological Sciences

Volumn 9, Issue 2, 2013, Pages 219-227

  Tokunaga, Yuhei ^a   Sakakibara, Yukako ^a   Kamada, Yoshiki ^a   Watanabe, Kei Ichi ^a,b   Sugimoto, Yasushi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b SAGA UNIVERSITY   (Japan)

Author keywords

Amyloid fibril formation; Core region; Egg white; Lysozyme; Tryptophan

Indexed keywords

AMINO ACID; AMYLOID; HEN EGG LYSOZYME; LYSOZYME; OLIGOPEPTIDE; TRYPTOPHAN;

AMYLOID FIBRIL FORMATION; ANIMAL; ARTICLE; ATOMIC FORCE MICROSCOPY; BIOPHYSICS; CHEMICAL STRUCTURE; CHICKEN; CORE REGION; EGG WHITE.; FLUORESCENCE; GENETICS; HUMAN; KINETICS; PH; PROTEIN SECONDARY STRUCTURE; TEMPERATURE; TRANSMISSION ELECTRON MICROSCOPY;

AMYLOID FIBRIL FORMATION; CORE REGION; EGG WHITE.; LYSOZYME; TRYPTOPHAN;

AMINO ACIDS; AMYLOID; ANIMALS; BIOPHYSICS; CHICKENS; FLUORESCENCE; HUMANS; HYDROGEN-ION CONCENTRATION; KINETICS; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, ELECTRON, TRANSMISSION; MODELS, MOLECULAR; MURAMIDASE; OLIGOPEPTIDES; PROTEIN STRUCTURE, SECONDARY; TEMPERATURE;

EID: 84874372752     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.5380     Document Type: Article

References (45)

1. Veerhuis R, Boshuizen RS, Familian A. Amyloid associated proteins in Alzheimer's and prion disease. Curr. Drug Targets CNS Neurol. Disord. 2005; 4: 235-248.
2. Aarsland D, Perry R, Brown A, Larsen JP, Ballard C. Neuropathology of dementia in Parkinson's disease: a prospective, community-based study. Ann. Neurol. 2005; 58: 773-776.
3. Chakraborty C, Nandi S, Jana S. Prion disease: a deadly disease for protein misfolding. Curr. Pharm. Biotechnol. 2005; 6: 167-177.
4. Kelly JW. Alternative conformations of amyloidogenic proteins govern their behavior. Curr. Opin. Struct. Biol. 1996; 6: 11-17.
5. Kelly JW. The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. Curr. Opin. Struct. Biol. 1998; 8: 101-106.
6. Dobson CM. Protein folding and misfolding. Nature 2003;426: 884-890.
7. Frandrich M, Fletcher MA, Dobson CM. Amyloid fibrils from muscle myoglobin. Nature 2001; 410: 165-166.
8. Chiti F, Dobson CM. Amyloid formation by globular proteins under native conditions. Nat. Chem. Biol. 2009; 5: 15-22.
9. Callewaert L, Michiels CW. Lysozymes in the animal kingdom. J. Biosci. 2010; 35: 127-160.
10. Lesnierowsli G, Kjowski J. Lysozyme. In: Huopalahti R, Lopez-Fandino R, Anton M, Schade R, eds. Bioactive Egg Compounds. Berlin Heiderberg: Springer-Verlag. 2007: 34-42.
11. Mishra R, Sorgjerd K, Nystrom S, Nordigarden A, Yu YC, Hammarstrom P. Lysozyme amyloidogenesis is accelerated by specific nicking and fragmentation but decelerated by intact protein binding and conversion. J. Mol. Biol. 2007; 399: 1029-1044.
12. Morozova-Roche LA, Zurdo J, Spencer A, Noppe W, Receveur V, Archer DB, Joniau M, Dobson CM. Amyloid fibril formation and seeding by wild-type human lysozyme and its disease-related mutational variants. J Struct Biol. 2000; 130: 339-3351.
13. Goda S, Takano K, Yamagata Y, Nagata R, Akutsu H, Maki S, Namba K, Yutani K. Amyloid protofilament formation of hen egg lysozyme in highly concentrated ethanol solution. Protein Sci. 2000; 9: 369-375.
14. Cao A, Hu D, Lai L. Formation of amyloid fibrils from fully reduced hen egg white lysozyme. Protein Sci. 2004; 13: 319-324.
15. Swaminathan R, Ravi VK, Kumar S, Kumar MV, Chandra N. Lysozyme: a model protein for amyloid research. Adv. Protein Chem. Struct. Biol. 2011; 84: 63-111.
16. Xu M, Shashilov VA, Ermolenkov VV, Fredriksen L, Zagorevski D, Lednev IK. The first step of hen egg white lysozyme fibrillation, irreversible partial unfolding, is a two-state transition. Protein Sci. 2007; 16: 815-832.
17. Frare E, Polverino De Laureto P, Zurdo J, Dobson CM, Fontana A. A highly amyloidogenic region of hen lysozyme. J. Mol. Biol. 2004; 340: 1153-1165.
18. Verma D, Jacobs DJ, Livesay DR. Changes in Lysozyme Flexibility upon Mutation Are Frequent, Large and Long-Ranged. PLoS Comput Biol. 2012; 8: 1-18.
19. Sugimoto Y, Kamada Y, Tokunaga Y, Shinohara H, Matsumoto M, Kusakabe T, Ohkuri T, Ueda T. Aggregates with lysozyme and ovalbumin show features of amyloid-like fibrils. Biochem Cell Biol. 2011; 89: 533-544.
20. Wirmer J, Schlorb C, Klein-Seetharaman J, Hirano R, Ueda T, Imoto T, Schwalbe H. Modulation of compactness and long-range interactions of unfolded lysozyme by single point mutations. Angew. Chem. Int. Ed. Engl. 2004; 43: 5780-5785.
21. Ohkuri T, Shioi S, Imoto T, Ueda T. Effect of the structure of the denatured state of lysozyme on the aggregation reaction at the early stages of folding from the reduced form. J. Mol. Biol. 2009; 347: 159-168.
22. Klein-Seetharaman J, Oikawa M, Grimshaw SB, Wirmer J, Duchardt E, Ueda T, Imoto T, Smith LJ, Dobson CM, Schwalbe H. Long-range interactions within a nonnative protein. Science. 2002; 295:1719-1722.
23. Zhou R, Eleftheriou M, Royyuru AK, Berne BJ. Destruction of long-range interactions by a single mutation in lysozyme. Proc Natl Acad Sci U S A. 2007; 104:5824-5829.
24. Mishima T, Ohkuri T, Monji A, Imoto T, Ueda T. A particular hydrophobic cluster in the residual structure of reduced lysozyme drastically affects the amyloid fibrils formation. Biochem. Biophys. Res. Commun. 2007; 356: 769-772.
25. Pertinhez TA, Bouchard M, Smith RA, Dobson CM, Smith LJ. Stimulation and inhibition of fibril formation by a peptide in the presence of different concentrations of SDS. FEBS Lett. 2002; 529: 193-197.
26. Nilsson MR. Techniques to study amyloid fibril formation in vitro. Methods 2004; 34: 151-160.
27. Molla AR, Maity SS, Ghosh S, Mandal DK. Organization and dynamics of tryptophan residues in tetrameric and monomeric soybean agglutinin: studies by steady-state and time-resolved fluorescence, phosphorescence and chemical modification. Biochimie. 2009; 91: 857-867.
28. Yang JT, Wu CSC, Martinez HM. Calculation of protein conformation from circular dichroism. Methods in Enzymol. 1986; 130: 208-269.
29. Chiti F, Dobson CM. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 2006; 75: 333-366.
30. Moore RA, Taubner LM, Priola SA. Prion protein misfolding and disease. Curr. Opin. Struct. Biol. 2009; 19: 14-22.
31. Trexler AJ, Nilsson MR. The formation of amyloid fibrils from proteins in the lysozyme family. Curr. Protein Pept. Sci. 2007; 8: 537-557.
32. Fontana A, de Laureto PP, Spolaore B, Frare E, Picotti P, Zambonin M. Probing protein structure by limited proteolysis. Acta Biochim. Pol. 2004; 51: 299-321.
33. Krebs MR, Wilkins DK, Chung EW, Pitkeathly MC, Chamberlain AK, Zurdo J, Robinson CV, Dobson CM. Formation and seeding of amyloid fibrils from wild-type hen lysozyme and a peptide fragment from the beta-domain. J. Mol. Biol. 2000; 300: 541-549.
34. Blake C, Serpell L. Synchrotron X-ray studies suggest that the core of the transthyretin amyloid fibril is a continuous beta-sheet helix. Structure 1996; 4: 989-998.
35. Xu S. Cross-beta-sheet structure in amyloid fiber formation. J. Phys. Chem. B. 2009; 113: 12447-1255.
36. Demarest SJ, Fairman R, Raleigh DP. Peptide models of local and long-range interactions in the molten globule state of human alpha-lactalbumin. J. Mol. Biol. 1998; 283: 279-291.
37. Demarest SJ, Horng JC, Raleigh DP. A protein dissection study demonstrates that two specific hydrophobic clusters play a key role in stabilizing the core structure of the molten globule state of human alpha- lactalbumin. Proteins 2001; 42: 237-242.
38. Eftink MR, Ghiron CA. Fluorescence quenching studies with proteins. Anal. Biochem. 1981; 114: 199-227.
39. Vanhove M, Lejeune A, Pain RH. Beta-lactamases as models for protein- folding studies. Cell Mol. Life Sci. 1998; 54: 372-377.
40. Pepys MB, Hawkins PN, Booth DR, Vigushin DM, Tennent GA, Soutar AK, Totty N, Nguyen O, Blake CC, Terry CJ, et al. Human lysozyme gene mutations cause hereditary systemic amyloidosis. Nature 1993; 362: 553-557.
41. Valleix S, Drunat S, Philit JB, Adoue D, Piette JC, Droz D, MacGregor B, Canet D, Delpech M, Grateau G. Hereditary renal amyloidosis caused by a new variant lysozyme W64R in a French family. Kidney Int. 2002; 61: 907-912.
42. Yazaki M, Farrell SA, Benson MD. A novel lysozyme mutation Phe57Ile associated with hereditary renal amyloidosis. Kidney Int. 2003; 63: 1652-1657.
43. Rocken C, Becker K, Fandrich M, Schroeckh V, Stix B, Rath T, Kahne T, Dierkes J, Roessner A, Albert FW. ALys amyloidosis caused by compound heterozygosity in exon 2 (Thr70 Asn) and exon 4 (Trp112Arg) of the lysozyme gene. Hum. Mutat. 2006; 27: 119-120.
44. Kumita JR, Johnson RJ, Alcocer MJ, Dumoulin M, Holmqvist F, McCammon MG, Robinson CV, Archer DB, Dobson CM. Impact of the native-state stability of human lysozyme variants on protein secretion by Pichia pastoris. FEBS J. 2006; 273: 711-720.
45. Granel B, Valleix S, Serratrice J, Cherin P, Texeira A, Disdier P, Weiller PJ, Grateau G. Lysozyme amyloidosis: report of 4 cases and a review of the literature. Medicine (Baltimore) 2006; 85: 66-73.